Joshua T. Schiffer, Charles A. Schiffer. To what extent can mathematical modeling inform the design of clinical trials? The example of safe dose reduction of tyrosine kinase inhibitors in responding patients with chronic myeloid leukemia. haematol [Internet]. 2018Oct.31 [cited 2024Apr.16];103(11):1756-7. Available from: https://haematologica.org/article/view/8652